For more information, visit https://www.miltenyibiotec.com/lp/virtual-macs-covid-19-day.html Listen to expert talks, roundtable discussions and question and answer sessions from our Virtual MACS COVID-19 Day.

To give you an insight into the latest discoveries on SARS-CoV-2 and promote scientific networking, we hosted a virtual event full of interesting talks and round table discussions with several experts who shared their latest findings in COVID-19 research.
_______________________________________________

Content of the video

00:00 Introduction
02:50 TALK 1 - Professor Leung Wing Hang - Cytokine Capture System for SARS-CoV-2 specific T cells
44:14 TALK 2 - Professor Eric Vivier - The role of C5a-C5AR1 in Covid-19
01:32:14 TALK 3 - Professor Alexander Scheffold - Deep profiling of SARS-CoV-2-specific T cells from healthy donors and COVID-19 patients using ARTE
02:11:34 - TALK 4 - Dr. Susanne Bethke - SARS-CoV-2 proteins and analysis of humoral immunity in COVID-19 patients
02:40:15 TALK 5 - Professor Rafael Correa Rocha - Treg cell therapy as a new approach to prevent the immune hyperactivation responsible for the clinical worsening of COVID-19
03:21:29 TALK 6 - David Leclerc - Managing cell sorting of biohazardous samples during the COVID-19 pandemic
03:51:43 Closing

_______________________________________________
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging.. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.